Transverse sinus stenting is a minimally invasive endovascular procedure used to treat idiopathic intracranial hypertension (IIH)—a condition marked by elevated pressure in the brain without a detectable mass or lesion by relieving venous outflow obstruction in the transverse sinus.
include chronic headaches, visual disturbances (such as blurred vision or papilledema), pulsatile tinnitus, and in severe cases, vision loss. These symptoms are often linked to impaired cerebrospinal fluid (CSF) drainage due to transverse sinus stenosis.
Involves placing a stent in the narrowed transverse sinus to restore normal venous drainage, reduce intracranial pressure, and alleviate symptoms. Studies show that stenting can eliminate papilledema in over 90% of cases, reduce or eliminate the need for medications like acetazolamide, and preserve vision with a low complication rate.
We will contact you soon.